Background
==========

The disinfection of public drinking water over the past century has dramatically decreased infectious waterborne diseases and is a hallmark of American public health policy. The benefits of drinking water disinfection are well recognized, however, an undesirable side effect is the production of disinfection by-products (DBPs). These DBPs are formed when disinfectants such as chlorine, chloramine, and ozone react with organic and inorganic matter in water. In the mid 1970's, it was discovered that trihalomethanes (THMs) were produced in chlorination of drinking water and that they are carcinogenic in laboratory animals ([@b34-tog-1-2006-033]; [@b3-tog-1-2006-033]; NCI, 1976). Because of the potential health risks associated with THMs, in 1979 the U.S. Environmental Protection Agency (U.S. EPA) began the regulation of DBPs in the water supply. Initially, concern focused on the trihalomethanes (THMs), but it is now recognized that a wide variety of DBPs are produced during chlorination.

In an effort to reduce exposure to halogenated DBPs, many utilities have switched to ozonation as an alternative treatment method to chlorination. Ozonation is also preferred because it reduces the turbidity of the water and is effective in treating chlorine resistant organisms. However, if ozonation is performed using surface water high in bromide content, brominated by-products, such as bromate ion (BrO~3~^−^), can be generated ([@b12-tog-1-2006-033]). Potassium bromate (KBrO~3~), a salt of the bromate ion, is nephro- and neurotoxic in humans and carcinogenic in rodents ([@b14-tog-1-2006-033]; [@b18-tog-1-2006-033]). Under the current guidelines for cancer risk assessment ([@b47-tog-1-2006-033]), bromate is classified as a probable human carcinogen due to its kidney carcinogenicity in male and female rats following exposure in drinking water ([@b22-tog-1-2006-033], [@b20-tog-1-2006-033], [@b21-tog-1-2006-033]; [@b7-tog-1-2006-033]; [@b48-tog-1-2006-033]). A dose-response relationship in rat kidneys was observed in progressive severity from renal dysplastic foci, preneoplastic lesions, through renal adenomas, and finally renal carcinoma ([@b20-tog-1-2006-033]; [@b7-tog-1-2006-033]; [@b48-tog-1-2006-033]).

Mechanistic studies by [@b45-tog-1-2006-033], [@b45-tog-1-2006-033]) demonstrated dose-dependent changes in oxidative stress and cell proliferation parameters at carcinogenic doses of potassium bromate in male and female rat kidneys. After four weeks of continuous drinking water exposure, 8-oxodeoxyguanosine levels (8-oxodG), an indicator of promutagenic oxidative DNA damage ([@b49-tog-1-2006-033]; [@b38-tog-1-2006-033]), were significantly elevated in male and female rats administered potassium bromate at concentrations of 250 ppm and higher. In addition, BrdU labeling, an indicator of cell proliferation, was also increased in the proximal tubule of female rats at similar concentrations and in male rats at concentrations as low as 30 ppm. It was suggested, however, that the susceptibility of the male rat to increased cell proliferation at lower concentrations was probably attributable to increased α2u-globulin in the male rat proximal tubule. These studies provide important information regarding the potential mechanism of action of potassium bromate carcinogenicity.

The primary objective in this study was to examine renal gene expression differences in male F344 rats exposed to a non-carcinogenic and carcinogenic dose (20 and 400 ppm, respectively) of KBrO~3~ in drinking water for 52 wk. Furthermore, renal gene expression from the high dose (400 ppm) and adenomas from 100 wk exposed animals were examined and compared to the 52 wk exposure groups. This was accomplished by extracting kidney and adenoma RNA from rats exposed in the previous 1998 DeAngelo et al. study. Comparisons of gene expression profiles between these groups were used to identify functional pathways and individual genes that might contribute to the carcinogenic mechanism of action for KBrO~3~ and provide insight into potential biomarkers of exposure.

Methods
=======

Animal maintenance
------------------

Complete study details were published previously ([@b7-tog-1-2006-033]). Briefly, KBrO~3~ (99%; CAS 7758--01--2) dissolved in deionized water at concentrations of 0, 20, 100, 200, and 400 ppm was administered to male F344 rats as the sole water source for 12, 26, 52, 78, or 100 wk. Rats, 28 to 30-days-old, were allowed to acclimate for 1 wk and then randomly assigned to treatment groups. Treatment rooms were maintained at 20--22°C and 40--60% humidity with a 12-hr light: dark cycle. Rats were housed 3 per cage on wood chips and provided Purina Rodent Laboratory Chow (St. Louis, MO) and water ad libitum. Animals were observed daily and moribund animals were euthanized and necropsied. Six animals from each group were euthanized by CO~2~ asphyxiation and necropsied after 52 wk of treatment. At necropsy, kidneys were removed, washed, flash frozen in liquid nitrogen, and stored at −80°C.

Microarray experiment
---------------------

For the microarray experiment, rats exposed to 0, 20, and 400 ppm KBrO~3~ for 52 wk, were selected because they represent a control, non-carcinogenic, and carcinogenic dose, respectively ([@b7-tog-1-2006-033]; [@b48-tog-1-2006-033]). Kidneys from animals exposed to 20 and 400 ppm KBrO~3~ for 52 wk were compared to kidneys from 52 wk control animals. In addition, kidneys from rats exposed to 0 and 400 ppm KBrO~3~ and two adenomas from animals exposed for 100 wk were also examined. For this comparison, kidneys from the 100 wk high dose and adenomas were compared to kidneys from 100 wk control animals. Kidney RNA was extracted from three animals per dose group in the 52 wk exposure, and two animals per dose group in the 100 wk samples. RNA from two 100 wk adenomas were also extracted. RNA extraction was performed by acid guanidinium isothiocynate-phenol-bromoch-loropropane treatment (Tri reagent; Molecular Research Center, Inc., Cincinnati, OH, U.S.A.) and purified on an affinity resin (RNeasy; Qiagen, Valencia, CA) according to manufacturer instructions. Extractions were tested on an Agilent Bioanalyzer to determine RNA quality. Clearly defined 28S and 18S bands were observed on all samples used for microarray analysis. Samples showing degradation were not used for microarray analysis. Microarray procedures were performed as recommended by the manufacturer of the GeneChip system (Affymetrix, Inc, Santa Clara, CA, U.S.A.). The gene expression probe array used was the Rat Expression Array 230A gene chip containing 15,866 probe sets. For each animal, one kidney sample was used for gene expression analysis. Chips were examined by M versus A plots, chip clustering, and principal component analysis to determine outlying chips. Arrays demonstrating poor hybridization were not used for analysis.

Data analysis
-------------

The resulting image files (.cel) were normalized using the procedure of [@b25-tog-1-2006-033]; [@b26-tog-1-2006-033]) and the determination of significant differences between groups were performed by using the web interface of Cyber-T \[<http://visitor.ics.uci.edu/genex/cybert/>\]([@b1-tog-1-2006-033]). A tutorial for using both D-chip and Cyber-T, found on the Cyber-T website, was used as the procedure for this analysis. Multiple testing correction and false discovery rate test were conducted by using the method of [@b4-tog-1-2006-033] on P-values: *P = \< (i/m)q*, where *i* = \# of genes accepted at selected *p, m* = total \# genes, and *q* = desired false discovery rate. Determination of false positives was performed by: *fp* = (Pbh \* total \# genes). This resulted in a unique P-value for each comparison. Genes expressed at levels different than control such that a corrected P-value less than 0.05 were classified as differentially expressed genes (DEG) and annotated using NetAffx (<http://www.affymetrix.com>). Individual literature review on each DEG was conducted and used to classify genes into functional groups.

Kidney developmental gene response in KBrO~3~ induced adenoma
-------------------------------------------------------------

Gene expression analysis has become sufficiently standardized that comparisons between experimental datasets can yield insights into biological processes such as the differentiation of renal cells. In this vein, we compared our dataset of gene expression in whole adult rat kidney to that collected and analyzed by [@b41-tog-1-2006-033]. This study performed the first high density oligonucleotide microarray investigation of kidney development using the 8,740 gene Affymetrix rat U34A microarray. Multiple developmental stages were examined, including embryonic day 13 (E13), E15, E17, E19, newborn, 1 wk, and adult. Cluster analysis defined five temporal expression groups. Early group consisted of genes with very high expression in the early embryonic kidney, many with roles in protein translation and DNA replication. Prenatal group consisted of genes that peaked in mid-embryogenesis and contained many transcripts specifying proteins of the extracellular matrix. Neonatal group consisted of transcripts that peaked in the neonatal period and contained a number of retrotransposon RNAs. Steady group contained genes that steadily increased in relative expression levels throughout development, including many genes involved in energy metabolism and ion and water transport. Adult group consisted of genes with relatively low levels of expression throughout embryogenesis but with markedly higher levels in the adult kidney; this group included a heterogeneous mix of transporters, detoxification enzymes, and oxidative stress genes.

Lists of the five groups of genes identified in [@b41-tog-1-2006-033], were obtained from the supplemental data website (<http://organogenesis.ucsd.edu/>). These gene-lists used U34A probe set identifiers. We determined the Rat Expression Array 230A probe set identifiers that corresponded to the U34A probe sets using the best match comparison file from Affymetrix. For the five kidney development groups mentioned above, there were 838, 168, 61, 510, and 193 genes located on the U34 array and 676, 126, 42, 428, and 155 genes located on the Rat Expression Array 230A array. The minimum sequence identity for a given probe set between the U34A and Rat Expression Array 230A array was 93% and the average identity was greater than 99%. For each group, the genes that were identified in the Affymetrix best match comparison file constituted the gene members for that group in subsequent analysis.

Real time PCR determination of gene expression
----------------------------------------------

Quantitative real-time rtPCR (QRT-rtPCR) data was collected from fresh aliquots of the total RNA samples used to obtain array data. On average, 85 ng of total RNA was loaded in a one-step QRT-rtPCR reaction. Multiscribe reverse transcriptase was used to generate the cDNA template followed by amplification with AmpliTaq Gold DNA polymerase (Applied Biosystems). Target specific assays were either custom designed or purchased from Applied Biosystems' TaqMan Assays on Demand. All reactions were performed according to manufacturer's procedures. The QRT-rtPCR cycling parameters were: 48°C, 45 min cDNA synthesis; 95°C, 10 min AmpliTaq Gold (Applied Biosystems) activation; and 40 cycles of amplification at 94°C, 15 sec melting followed by 60°C, 1 min annealing/extension. Reaction volumes totaled 20 *μ*l and were run in triplicate in 384 well plates on an ABI prism 7900HT. Based on the array data, *Rpl*27 (ribosomal protein L27) was chosen as a reference gene since it exhibited no differential gene expression across treatment groups and showed similar expression levels to the genes of interest. Confirmation that *Rpl*27 was not differentially expressed across treatment groups was confirmed by QRT-rtPCR analysis (data not shown).

Results
=======

Microarray analysis
-------------------

The results of the statistical comparison among tissues from the 52 wk control, low, and high dose groups, and the 100 wk control, high, and adenoma groups are given in [Table 1](#t1-tog-1-2006-033){ref-type="table"}. This study has been archived in ArrayExpress under accession number E-TOXM-21.

Analysis of gene expression
---------------------------

Gene ontology (GO) analysis of DEG expression in the kidney from male F344 rats exposed to low (20 ppm) and high (400 ppm) KBrO~3~ for 52 wk are shown in [Table 2](#t2-tog-1-2006-033){ref-type="table"}. The individual functional group information composed of gene symbol and name, Affymetrix and accession numbers, and fold change are given for oxidative stress ([Table 3](#t3-tog-1-2006-033){ref-type="table"}), and kidney function / ion transport ([Table 4](#t4-tog-1-2006-033){ref-type="table"}) genes. In addition to the above mentioned groups, a large amount of lipid metabolism, oxidoreductase, and cellular function genes were observed and are shown as additional files: "lipid metabolism table.pdf, oxidoreductase table.pdf and cellular function table.pdf. " A total of 99 and 139 genes were used to provide an interpretive basis for differences in expression that were observed in the kidneys of rats treated with non-carcinogenic and carcinogenic doses, respectively.

Analysis of the low dose showed a general suppression of gene expression with 71% of genes down-regulated relative to control tissues compared to 56% in the high dose. The most notable down-regulated groups in the low dose were oxidative stress and kidney function with 100% and 77% down-regulated, respectively. In the high dose, 87% of genes in kidney function and 90% of genes in lipid metabolism groups were down-regulated. Overall these changes suggest a general suppression of gene expression in the low dose group, especially those genes involved in oxidative stress and kidney function. This is in contrast to the high dose, where kidney function and lipid metabolism genes are suppressed in concert with an increased amount of oxidative stress related genes.

A comparison of genes whose expression was significantly altered in the 52 wk high dose (400 ppm) and the 100 wk adenomas is given as an additional file: "similar 52,100, adenomas.pdf." In this comparison, 35 genes were down-regulated relative to the kidney of control animals, 3 were up-regulated, and 9 genes did not show the same direction of change. The majority of these down-regulated genes were associated with kidney function.

A common list of genes whose expression was significantly altered relative to control tissue in the 52 wk high (400 ppm), the 100 wk high (400 ppm), and the 100 wk adenoma groups is given in [Table 5](#t5-tog-1-2006-033){ref-type="table"}. In most cases, the magnitude of fold change increases with duration of exposure and/or in tumor tissue. These genes may represent potential biomarkers of bromate exposure and effect because the magnitude of their alteration is time-dependent and/or a larger number of renal cells incorporate these transcript changes with continued exposure. Since tumor tissue is theoretically the product of clonal expansion of target cells, these eight genes might also aid in the development of useful tumor markers of KBrO~3~ carcinogenicity. These genes were: *Calb*1 (Calbindin 1), *Gp*2 (Glycoprotein 2), *Klk*7 (Kallikrein 7), an EST (LOC362802), *Ngfg* (Nerve growth factor, gamma), *Prps*2 (Phosphoribosyl pyrophosphate synthetase 2), *Slc*12*a*3 (Solute carrier family 12, member 3), and *Slc*26*a*4 (Solute carrier family 26, member 4).

Kidney developmental gene response in KBrO~3~ induced adenoma
-------------------------------------------------------------

The processes involved in organ development, including cell proliferation, apoptosis, cell adhesion, and differentiation, are processes that are disregulated during carcinogenesis. Therefore, a comparison was made between a previous gene expression profile observed in rat kidney development to that of the kidney adenoma profile from this study. [@b41-tog-1-2006-033] identified five groups of genes whose expression characterized stages of rat kidney development. As described in the Methods, genes were identified in the current study that matched specific development groups. [Figure 1A](#f1A-tog-1-2006-033){ref-type="fig"} shows the average fold change of each group compared to control for low bromate, high bromate and adenoma. Early and prenatal genes, associated with cell proliferation and laying down the extracellular matrix, are up-regulated in the adenoma. Steady and adult genes, associated with energy metabolism, transport, detoxification, and oxidative stress response, are down-regulated in the adenoma. This adenoma expression profile shows the up-regulation of genes prevalent in early kidney development and down-regulation of adult stage genes. This observation is in agreement with the proliferation and de-differentiation profiles seen in classical tumor development.

Adenoma expression profile resemble high dose bromate kidney
------------------------------------------------------------

The adenoma demonstrated an expression profile for kidney development gene groups early, prenatal, steady, and adult that was distinct from control and bromate treated kidneys. In order to determine if the adenoma profile, as determined above, was present in part, in either the low or high KBrO~3~ exposed animals, the top ten DEGs were selected from each of the four groups mentioned above. [Figure 1B](#f1B-tog-1-2006-033){ref-type="fig"} shows the average fold change of each group compared to control for low and high dose bromate. This figure illustrates that the high dose kidney, but not the low, did resemble the adenoma expression pattern with the early and prenatal phase genes being up-regulated and the steady and adult phase genes being down-regulated.

Real time PCR determination of gene expression
----------------------------------------------

Quantitative Real Time rtPCR assays were conducted to verify gene expression of genes deemed biologically relevant based on pathway analysis and genes that could possibly be used as biomarkers of exposure. [Figure 2](#f2-tog-1-2006-033){ref-type="fig"} shows that QRT-rtPCR results confirmed the expression patterns of the genes tested. However, differences in magnitude of change were observed, for example *Aqp*2 shows a −1.4 microarray fold change, but an −18.5 QRT-rtPCR fold change. This discrepancy in the magnitude of fold change between micro-array data and rtPCR data has been noted in other genomics studies and may be attributable to the superior utility of the rtPCR procedure in quantifying transcript abundance ([@b6-tog-1-2006-033]). The specific genes selected, including target sequence are given in additional file: "QRT-rtPCR_table.pdf ."

Discussion
==========

In the [@b7-tog-1-2006-033] and [@b48-tog-1-2006-033] studies, male F344 rats exposed to 400 ppm KBrO~3~ for 52 wk developed kidney cancer, while those exposed to 20 ppm did not. This study used the same animal kidneys from that study to determine if a difference in gene expression could be discerned between the two doses. Examining global gene expression for each dose allowed categorizing of genes into the following groups; oxidative stress, lipid metabolism, kidney function/ion transport, cellular function, and oxidoreductase function.

Oxidative stress response
-------------------------

Reactive oxygen species (ROS) are natural by-products produced by the metabolism of O~2~ during aerobic respiration. Oxidative stress occurs when there are increases in ROS production, and/or depressed antioxidant defense. Glutathione (GSH) is an important component of the antioxidant and detoxification systems in most tissues. However, under normal cellular conditions, KBrO~3~ induces oxidative DNA damage in the form of 8-oxode-oxyguanosine (8-oxodG) that is dependent on GSH and other sulfhydryls ([@b2-tog-1-2006-033]; [@b30-tog-1-2006-033]). Bromate-induced oxidative DNA damage is caused by the reduction of bromate to bromine oxides and bromine radicals generated by sulfhydryls like GSH. *In vivo*, it has been suggested that sulfhydryls, present at the brush borders of the proximal convoluted tubule ([@b52-tog-1-2006-033]), are important in the generation of bromine oxides and bromine radicals ([@b30-tog-1-2006-033]). The relative reduction of extracellular and intracellular bromate and its metabolites also affect the delivery of bromate ions to target macro-molecules. Under high dose conditions, more bromate may be delivered to target cells for intracellular activation due to reduced systemic metabolism and/or antioxidant defenses ([@b8-tog-1-2006-033]).

Altered gene expression associated with oxidative stress in the low dose gave only four down-regulated genes *Dscr*1*, Hspb*1*, Txnrd*1*, and Xdh.* It has been reported that in oxidative stress conditions, *Dscr*1*, Hspb*1*,* and *Txnrd*1 are elevated ([@b10-tog-1-2006-033]; [@b9-tog-1-2006-033]; [@b50-tog-1-2006-033]), and increased levels of *Xdh* are associated with free radical generation ([@b35-tog-1-2006-033]). *Dscr*1 is regulated by both oxidative stress and Ca+ levels ([@b27-tog-1-2006-033]), thus it may be influenced more by Ca+ ion concentration than oxidative stress. Although these genes are associated with oxidative stress, they are all down-regulated and appear to reflect inhibition, chronic adaptation, or simply no induction of oxidative stress in animals exposed to 20 ppm KBrO~3~.

A larger involvement of proposed oxidative stress genes are seen in the high dose group with 10 DEG; 5 down- and 5 up-regulated. In the high dose response, the *Dscr*1 and a heat-shock gene *Hspbap*1, which are up-regulated in response to ROS, are down-regulated in this study. This is an unexpected response following exposure to a known producer of ROS. However, the expression observed in this experiment is that of a kidney chronically exposed to a carcinogenic dose of KBrO~3~, and may represent an adaptive gene response. Two additional down-regulated genes, *Gnmt* and *Gsta*2, are involved with GSH homeostasis and GSH conjugation, respectively.

The up-regulated oxidative stress genes include *Ccng*1*, Cp, Gclm*, and two glutathione transferases, *Gstm*1 and *Gstp*1. Studies have demonstrated that cyclin G1 (*Ccng*1) plays roles in G2/M arrest, damage recovery, and growth promotion after cellular stress ([@b16-tog-1-2006-033]). Cyclin G1 accomplishes this by regulating the activity of p53 ([@b15-tog-1-2006-033]). This may indicate possible oxidative stress induced DNA damage followed by increased cellular proliferation. *Cp* is a plasma protein that is up-regulated in response to oxidative stress and functions as a copper transporter and antioxidant. *Gclm* is involved in glutathione biosynthesis and is up-regulated as a defensive response to oxidative stress ([@b28-tog-1-2006-033]). Two glutathione S-transferases are up-regulated, *Gstm*1 and *Gstp*1. Both are involved in the conjugation of reduced GSH to a wide number of exogenous and endogenous hydrophobic electrophiles. Taken together, these data support the finding that KBrO~3~ does produce an oxidative stress response in the kidney at high doses, however the magnitude of expression was not large, resulting in ten genes with relatively small fold-change. This may be characteristic of a kidney that has developed a resistant morphological phenotype to KBrO~3~-induced oxidative stress due to long-term chronic exposure.

Lipid metabolism
----------------

Altered lipid metabolism and lipid peroxidation have been associated with KBrO~3~ exposure ([@b5-tog-1-2006-033]). Cellular fatty acids are readily oxidized by reactive oxygen species to produce lipid peroxyl radicals and lipid hydroperoxides ([@b33-tog-1-2006-033]). It is generally accepted that oxidative stress can lead to the oxidative degradation of lipids ([@b29-tog-1-2006-033]), which can disrupt normal lipid metabolism. Examination of genes associated with lipid metabolism in the low dose exposure showed 6 down-regulated (*Apoe, Cebpb, Chk, Cyp*2*e*1*, Cyp*4*a*10*, and Fads*1) and 4 up-regulated genes (*Abcg*1, *Calca, Gpd*2*, and Nr*1*d*1). The down-regulated genes dealt primarily with fatty acid metabolism and lipid biosynthesis, while the up-regulated genes were associated with lipid homeostasis and metabolism. In the high dose, nine genes were down-regulated (*Acaa*2*, Acsl*3*, Apoc*3*, Apom, Cyp*2*e*1*, Cyp*4*a*10*, Edn*1*, Ehhadh, Hadhsc*), and one up-regulated (*Fabp*5). These genes were primarily involved in fatty acid and lipid metabolism. Overall, gene expression for lipid metabolism is suppressed, with only one up-regulated gene observed in the high dose, contrary to expectations of KBrO~3~ induced lipid peroxidation. This is consistent with the work of [@b45-tog-1-2006-033] which contained no evidence of lipid peroxidation by chronic treatment of rats with carcinogenic doses of KBrO~3~.

Kidney function and ion transport
---------------------------------

The location of DEG genes involved with kidney function and ion transport within the nephron of the kidney is shown in [Figure 3](#f3-tog-1-2006-033){ref-type="fig"}. For the low dose ([Fig. 3A](#f3-tog-1-2006-033){ref-type="fig"}), of the 9 genes where specific locations could be identified, 6 were in the proximal convoluted tubules (PCT), 2 in the ascending loop of Henle (LH), and 1 in the distal convoluted tubules (DCT). Within the PCT, only the kidney specific organic anion transporter was up-regulated. For the high dose ([Fig. 3B](#f3-tog-1-2006-033){ref-type="fig"}), 7 genes were found in the PCT, 4 in the ascending LH, 5 in the DCT, and 6 genes in the collecting duct (CD). All genes in the PCT and CD were down-regulated, whereas *Slc*12*a*1 and *Cldn*16 were up-regulated in the ascending loop and *Agtr*2 was up-regulated in the DCT. When comparing the low and high figures, the high dose has more altered gene expression in the PCT and significantly more gene involvement down-stream of the PCT with 14 altered genes compared to only 3 in the low. The localized gene expression changes depicted in this figure reinforce the hypothesis that as the KBrO~3~ dose increases, additional cellular alterations occur in the PCT. As these changes occur, altered gene expression within and down-stream of the PCT is initiated as an attempt to maintain kidney function.

Kidney function and ion transport gene expression in the kidney from the 20 ppm exposure group showed a total of 10 genes down- and 3 up-regulated. Within the down-regulated group were genes mainly dealing with transport of water (*Aqp*1), sodium (*Atp*1*a*1 and *Skg*), potassium (*Atp*1*a*1), glucose (*G*6*pc*), and organic cations (*Slc*22*a*1). Although *Aqp*1 was down-regulated, no increase in water consumption was observed. In the upregulated group were genes involved in calcium homeostasis (*Calca*), magnesium and calcium transport (*Cldn*16), and organic anion transport (Slc21*a*4). These gene expression changes suggest a physiological response that helps maintain electrolyte balance in light of the chronic, low dose KBrO~3~ exposure. Although the low concentration of KBrO~3~ used in this study (20 ppm) was not carcinogenic, results from a similar study using a dose of 60 ppm in the drinking water found increased proliferation and mild degeneration of the proximal convoluted tubules ([@b45-tog-1-2006-033]). However, data collected in this paper indicate that physiological adaptation to KBrO~3~ exposure is beginning to occur even at a non-carcinogenic dose.

Kidney function and ion transport gene expression in the kidney from the 400 ppm exposure group showed 20 down- and 4 up-regulated genes. Within the down-regulated group were genes involved with transport of water (*Aqp*2*,* and *Aqp*3), calcium (*Calb*1), chloride (*Clcnk*11 and *Prkwnk*4*, Slc*12*a*3*,* and *Slc*26*a*4), potassium (*Kcnj*16, *Kcnq*1, and *Prkwnk*4), sodium (*Ngfg, Prkwnk*4*, Scnn*1*a, Scnn*1*g, Slc*5*a*2*, Slc*9*a*3*, Slc*12*a*3*, and Slc*13*a*3), organic ions (*Slc*22*a*5 and *Slc*22*a*8), glucose (*Slc*5*a*2 and *Slc*37*a*4), and regulation of blood pressure (*End*1). In the up-regulated group were *Agtr*2, an angiotensin II receptor; *Cldn*16, a magnesium and calcium transporter (also up-regulated in the low dose); *Cp*, an iron transporter, and *Slc*12*a*1, a sodium, potassium, chloride co-transporter. These results imply significant alterations in the expression of genes involved in kidney function, and possibly decreased organ function.

In this light, when examining the [@b7-tog-1-2006-033] and [@b48-tog-1-2006-033] study, a dose-dependent increase in water consumption was observed starting at wk 4 and continuing through the duration of the study. Overall, it was determined that rats from the high dose (400 ppm) group drank over 30% more than controls. Taken together with the large number of down-regulated kidney function and ion transport genes from the high dose KBrO~3~ exposure, these data possibly indicate a kidney in chronic renal insufficiency/failure. This condition occurs when the kidneys are unable to conserve water as they perform their blood filtering function. The amount of water conserved is controlled by antidiuretic hormone (ADH), also known as vasopressin. ADH controls kidney osmosis by inserting water pores into the collecting ducts. The water pores, *Aqp*2 and 3, are responsible for the final adjustment of urine concentration. In the high dose animals, *Aqp*2 and 3 transcripts are down-regulated. This would result in fewer water pores in the collecting duct leading to increased amounts of dilute urine. With the increase in urine production, the kidney may respond to maintain ionic balance and blood volume by down-regulating the genes contributing to loss of nutrients and electrolytes and up-regulating transporter genes necessary for reabsorption, such as *Slc*12*a*1 and *Cldn*16.

Within the high dose PCT and CD is a down-regulated gene called pendrin, or Slc26a4. Pendrin functions as a sodium-independent transporter of chloride and iodide where it is expressed in kidney, thyroid, and inner ear ([@b36-tog-1-2006-033]; [@b40-tog-1-2006-033]). It should be noted that KBrO~3~, in addition to being a kidney carcinogen, is also a thyroid carcinogen, and can cause deafness ([@b51-tog-1-2006-033]). Moreover, pendrin expression was lower in thyroid carcinomas than in normal thyroid tissue ([@b39-tog-1-2006-033]; [@b17-tog-1-2006-033]). Pendrin transcripts examined by QT-rtPCR in this study were not altered in the low dose (20 ppm), suppressed in high dose (400 ppm), and virtually absent in kidney adenomas, mirroring the results seen in the thyroid carcinomas. Due to pendrin already being identified as a biomarker in thyroid carcinogenesis, and its involvement in kidney function following KBrO~3~ exposure, we propose this gene as a possible biomarker of carcinogenic KBrO~3~ exposure.

Cellular function
-----------------

The primary objective of this study was to determine if a discernable difference in kidney gene expression could be observed between a non-carcinogenic and carcinogenic dose of KBrO~3~. Gene ontology analysis of altered gene expression revealed an accumulation of changes in the following functionally-related categories: cancer, cell cycle, cell death, cell-to-cell signaling and interaction, cellular development, and cellular growth and proliferation. Thus, the genes that fell into these categories were placed into a general cellular functional group for analysis. Within this group were 30 down- and 11 up-regulated genes in the low KBrO~3~ exposure group, and 20 down- and 22 up-regulated genes in the high exposure group.

In the low KBrO~3~ concentration, the majority of genes associated with cellular function were down-regulated (30 versus 11 up-regulated). Several low dose genes when down-regulated are associated with decreased cell proliferation and apoptosis (*Akap*12, *Arhb*, *Cebpb*, *Csf* 2*rb*, *Dusp*6, *Epim*, *Gadd*45*a*, *Id*2, *Id*3, *Ig f bp*3, *Ig f bp*6, *Jun*, *Pim*1, *Rgc*32, *Tieg*, and *Veg f b*). This is countered by only one up-regulated gene *Ccnd*1 (Cyclin d1), which is associated with increased cell proliferation and apoptosis. From this observation, it appears that the gene expression from the low dose kidney does not support increased levels of cell proliferation similar to the BrdU findings of [@b45-tog-1-2006-033] whose no-effect level was 15 mg/L.

The gene expression in the high KBrO~3~ concentration was more equally distributed with 22 down- and 20 up-regulated genes. There were 10 genes shared in the cellular function category between the low and high KBrO~3~ concentration. These were *Cyp*2*e*1, *Dscr*1, *Dsipi*, *F*3, *Id*2, *Ig f bp*1, *Ms*4*a*2, *Rgc*32, *Ptgds*, and *Vipr*1. All were directionally concordant except for *Ig f bp*1.

In contrast to the low dose, fewer genes were associated with cell proliferation and apoptosis (*Ccng*1, *Eno*1, *Hrasls*3, *Id*2, *Igfbp*1, *Madh*7, and *Nupr*1). *Eno*1 and *Hrasls*3, when down-regulated ([@b42-tog-1-2006-033]; [@b11-tog-1-2006-033]; [@b37-tog-1-2006-033]), and the up-regulated genes, *Nupr*1, and *Ccng*1 promote cellular growth and proliferation. However, *Id*2 and *Madh*7 when down-regulated support decreased proliferation ([@b24-tog-1-2006-033]; [@b23-tog-1-2006-033]). Although there are only a few genes in this group, the majority suggest increased cell proliferation and apoptosis.

Adenoma comparison
------------------

[@b41-tog-1-2006-033] established a benchmark expression profile for normal kidney development. By comparing the gene expression changes in the present study to this profile, expression changes that deviated from normal kidney were detected. In four defined kidney development groups, the 52 wk bromate-treated kidneys did not deviate from normal developmental patterns whereas the adenoma samples did. In these samples, the adenoma expression patterns were more characteristic of embryonic than adult kidneys. Although the bromate-treated kidneys did not show a strong expression pattern that matched the adenoma, the high dose kidney, but not the low, did resemble the adenoma expression pattern with genes prevalent in early kidney development being up-regulated and adult phase genes being down-regulated. This observation is in agreement with the proliferation and de-differentiation profiles seen in classical tumor development. Furthermore, the method of comparing developmental gene expression patterns between tumor and exposed animals could serve as a mechanism to identify biomarkers of tumor initiation.

Conclusion
==========

These data suggest the 400 ppm carcinogenic dose of KBrO~3~ showed marked gene expression differences from the non-carcinogenic dose. These include gene expression changes in oxidative stress and kidney function / ion transport genes. Comparison of kidney development gene expression showed that the adenoma patterns were more characteristic of embryonic than adult kidneys, and that the high dose kidney gene expression resembled an adenoma-like expression pattern. Taken together, these analyses from this study identify potential biomarkers of exposure and illuminate a possible carcinogenic mode of action for KBrO~3~.

Additional Files
================

File name: Oxidoreductase_table.pdf

File format: .pdf

Title of data: Oxidoreductase table

Description of data: List of differentially expressed oxidoreductase gene expression in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk.

File name: Lipid metabolism_table.pdf

File format: .pdf

Title of data: Lipid metabolism table

Description of data: List of differentially expressed lipid metabolism gene expression in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk.

File name: Cellular function_table.pdf

File format: .pdf

Title of data: Cellular function table

Description of data: List of differentially expressed cellular function gene expression in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk.

###### 

List of differentially expressed lipid metabolism genes in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. All comparisons were made between the specific treatment group and their corresponding control.

  Gene Symbol[^a^](#tfn6-tog-1-2006-033){ref-type="table-fn"}   Gene Name[^a^](#tfn6-tog-1-2006-033){ref-type="table-fn"}   Affymetrix No.[^a^](#tfn6-tog-1-2006-033){ref-type="table-fn"}   Accession No.[^a^](#tfn6-tog-1-2006-033){ref-type="table-fn"}   Fold Change
  ------------------------------------------------------------- ----------------------------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------- -------------
  Low dose                                                                                                                                                                                                                                                   
    *Apoe*                                                      Apolipoprotein E                                            1370862_at                                                       NM_138828                                                       −1.4
    *Cebpb*                                                     CCAAT/enhancer binding protein (C/EBP), beta                1387087_at                                                       NM_024125                                                       −1.5
    *Chk*                                                       Choline kinase alpha                                        1368692_a\_at                                                    NM_017127                                                       −1.7
    *Cyp2e1*                                                    Cytochrome P450, family 2, subfamily e1                     1367871_at                                                       NM_031543                                                       −1.4
    *Cyp4a10*                                                   Cytochrome P450, family 4, subfamily a10                    1368934_at                                                       NM_016999                                                       −1.4
    *Fads1*                                                     Fatty acid desaturase 1                                     1367857_at                                                       NM_053445                                                       −1.3
    *Abcg1*                                                     ATP-binding cassette, sub-family G, member 1                1368103_at                                                       NM_053502                                                       1.6
    *Calca*                                                     Calcitonin/calcitonin-related polypeptide, alpha            1370775_a\_at                                                    NM_017338                                                       1.4
    *Gpd2*                                                      Glycerol-3-phosphate dehydrogenase 2                        1369666_at                                                       NM_012736                                                       1.5
    *Nr1d1*                                                     Nuclear receptor subfamily 1, group D, member 1             1370816_at                                                       NM_145775                                                       1.7
  High dose                                                                                                                                                                                                                                                  
    *Acaa2*                                                     Acetyl-Coenzyme A acyltransferase 2                         1386880_at                                                       NM_130433                                                       −1.2
    *Acsl3*                                                     Acyl-CoA synthetase long-chain family member 3              1368177_at                                                       NM_057107                                                       −1.3
    *Apoc3*                                                     Apolipoprotein C-III                                        1370009_at                                                       NM_012501                                                       −1.6
    *Apom*                                                      Apolipoprotein M                                            1386980_at                                                       NM_019373                                                       −1.2
    *Cyp2e1*                                                    Cytochrome P450, family 2, subfamily e1                     1367871_at                                                       NM_031543                                                       −1.3
    *Cyp4a10*                                                   Cytochrome P450, family 4, subfamily a10                    1368934_at                                                       NM_016999                                                       −1.3
    *Edn1*                                                      Endothelin 1                                                1369519_at                                                       NM_012548                                                       −1.4
    *Ehhadh*                                                    3-hydroxyacyl coenzyme A dehydrogenase                      1368283_at                                                       NM_133606                                                       −1.4
    *Hadhsc*                                                    L-3-hydroxyacyl-Coenzyme A dehydrogenase                    1370237_at                                                       NM_057186                                                       −1.3
    *Fabp5*                                                     Fatty acid binding protein 5, epidermal                     1370281_at                                                       NM_145878                                                       1.4

Gene symbols and accession numbers from Affymetrix Netaffx (<http://www.affymetrix.com/analysis/index.affx>)

###### 

List of differentially expressed cellular function genes in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. All comparisons were made between the specific treatment group and their corresponding control.

  Gene Symbol[^a^](#tfn7-tog-1-2006-033){ref-type="table-fn"}   Gene Name[^a^](#tfn7-tog-1-2006-033){ref-type="table-fn"}   Affymetrix No.[^a^](#tfn7-tog-1-2006-033){ref-type="table-fn"}   Accession No.[^a^](#tfn7-tog-1-2006-033){ref-type="table-fn"}   Fold Change
  ------------------------------------------------------------- ----------------------------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------- -------------
  Low dose                                                                                                                                                                                                                                                   
    *Akap12*                                                    A kinase (PRKA) anchor protein (gravin) 12                  1368869_at                                                       NM_057103                                                       −1.8
    *Arhb*                                                      Ras homolog gene family, member B                           1369958_at                                                       NM_004040                                                       −1.5
    *Cebpb*                                                     CCAAT/enhancer binding protein (C/EBP), beta                1387087_at                                                       NM_024125                                                       −1.5
    *Csf2rb*                                                    Colony stimulating factor 2 receptor, beta 1                1369828_at                                                       NM_133555                                                       −1.3
    *Cyp2e1*                                                    Cytochrome P450 family 2, subfamily e1                      1367871_at                                                       NM_031543                                                       −1.4
    *Dscr1*                                                     Down syndrome critical region homolog 1                     1388686_at                                                       NM_153724                                                       −1.4
    *Dsipi*                                                     Delta sleep inducing peptide, immunoreactor                 1367771_at                                                       NM_031345                                                       −1.7
    *Dusp6*                                                     Dual specificity phosphatase 6                              1387024_at                                                       NM_053883                                                       −1.4
    *Epim*                                                      Epimorphin                                                  1372832_at                                                       NM_012748                                                       −1.4
    *F3*                                                        Coagulation factor 3                                        1369182_at                                                       NM_013057                                                       −1.6
    *Gadd45a*                                                   Growth arrest and DNA-damage-inducible 45 alpha             1368947_at                                                       NM_024127                                                       −1.4
    *Hba-a1*                                                    Hemoglobin alpha, adult chain 1                             1375519_at                                                       NM_013096                                                       −1.3
    *Hbb*                                                       Hemoglobin beta chain complex                               1371102_x\_at                                                    NM_033234                                                       −1.6
    *Id2*                                                       Inhibitor of DNA binding 2                                  1368870_at                                                       NM_013060                                                       −1.5
    *Id3*                                                       Inhibitor of DNA binding 3                                  1387769_a\_at                                                    NM_013058                                                       −1.5
    *Igfbp3*                                                    Insulin-like growth factor binding protein 3                1367652_at                                                       NM_012588                                                       −1.5
    *Igfbp6*                                                    Insulin-like growth factor binding protein 6                1372168_s\_at                                                    NM_013104                                                       −2.3
    *Jun*                                                       v-jun sarcoma virus 17 oncogene homolog                     1389528_s\_at                                                    NM_021835                                                       −1.6
    *Lgmn*                                                      Legumain                                                    1368430_at                                                       NM_022226                                                       −1.3
    *Mcl1*                                                      Myeloid cell leukemia sequence 1                            1370141_at                                                       NM_021846                                                       −1.6
    *Pim1*                                                      Serine threonine protein kinase                             1374429_at                                                       NM_017034                                                       −1.6
    *Ptgds*                                                     Prostaglandin D2 synthase                                   1367851_at                                                       NM_013015                                                       −1.4
    *Rgc32*                                                     Response gene to complement 32                              1368080_at                                                       NM_054008                                                       −1.8
    *Rhob*                                                      rhoB gene                                                   1369958_at                                                       NM_022542                                                       −1.4
    *Sgk*                                                       Serum/glucocorticoid regulated kinase                       1367802_at                                                       NM_019232                                                       −1.6
    *Tieg*                                                      Tgfb inducible early growth response                        1368650_at                                                       NM_031135                                                       −1.4
    *Txnrd1*                                                    Thioredoxin reductase 1                                     1386958_at                                                       NM_031614                                                       −1.3
    *Vegfb*                                                     Vascular endothelial growth factor B                        1380854_at                                                       AF022952                                                        −1.3
    *Xdh*                                                       Xanthine dehydrogenase                                      1369973_at                                                       NM_017154                                                       −1.4
    *Calca*                                                     Calcitonin/calcitonin-related polypeptide, alpha            1370775_a\_at                                                    NM_017338                                                       1.4
    *Ccnd1*                                                     Cyclin D1                                                   1383075_at                                                       NM_171992                                                       1.3
    *Dlgh4*                                                     Discs, large homolog 4                                      1371183_a\_at                                                    NM_019621                                                       2.0
    *Hand1*                                                     Heart and neural crest derivatives transcript 1             1370128_at                                                       NM_021592                                                       1.6
    *Ifng*                                                      Interferon gamma                                            1370790_at                                                       NM_138880                                                       1.9
    *Ms4a2*                                                     Membrane-spanning 4-domains, A2                             1369399_at                                                       NM_012845                                                       1.6
    *Nr1d1*                                                     Nuclear receptor subfamily 1, group D, member 1             1370816_at                                                       NM_145775                                                       1.7
    *Prlr*                                                      Prolactin receptor                                          1370384_a\_at                                                    NM_012630                                                       1.4
    *Siat1*                                                     Sialyltransferase 1                                         1370907_at                                                       NM_147205                                                       1.4
    *Vipr1*                                                     Vasoactive intestinal peptide receptor 1                    1387561_at                                                       NM_012685                                                       1.6
  High dose                                                                                                                                                                                                                                                  
    *Aldh1a1*                                                   Aldehyde dehydrogenase family 1, member A1                  1387022_at                                                       NM_022407                                                       −1.2
    *Calb1*                                                     Calbindin 1                                                 1370201_at                                                       NM_031984                                                       −1.3
    *Cyp2e1*                                                    Cytochrome P450, family 2, subfamily e1                     1367871_at                                                       NM_031543                                                       −1.3
    *Ddc*                                                       Dopa decarboxylase                                          1368064_a\_at                                                    NM_012545                                                       −1.5
    *Dscr1*                                                     Down syndrome critical region homolog 1                     1388686_at                                                       NM_153724                                                       −1.3
    *Dsipi*                                                     Delta sleep inducing peptide, immunoreactor                 1367771_at                                                       NM_031345                                                       −1.7
    *Edn1*                                                      Endothelin 1                                                1369519_at                                                       NM_012548                                                       −1.4
    *Eno1*                                                      Enolase 1, alpha                                            1367575_at                                                       NM_012554                                                       −1.3
    *F3*                                                        Coagulation factor 3                                        1369182_at                                                       NM_013057                                                       −1.4
    *Folh1*                                                     Folate hydrolase                                            1387363_at                                                       NM_057185                                                       −1.6
    *Hrasls3*                                                   HRAS like suppressor                                        1370202_at                                                       NM_017060                                                       −1.3
    *Hrg*                                                       Histidine-rich glycoprotein                                 1368583_a\_at                                                    NM_133428                                                       −2.0
    *Id2*                                                       Inhibitor of DNA binding 2                                  1368870_at                                                       NM_013060                                                       −1.5
    *Madh7*                                                     MAD homolog 7                                               1368896_at                                                       NM_030858                                                       −1.5
    *Ptgds*                                                     Prostaglandin D2 synthase                                   1367851_at                                                       NM_013015                                                       −1.5
    *Rgc32*                                                     Response gene to complement 32                              1368080_at                                                       NM_054008                                                       −1.7
    *Sdc4*                                                      Syndecan 4                                                  1367721_at                                                       NM_012649                                                       −1.2
    *Serpinf1*                                                  Serine (or cysteine) proteinase inhibitor, clade F1         1388569_at                                                       NM_177927                                                       −1.3
    *Sp3*                                                       Sp3 transcription factor                                    1375384_at                                                       AI715114                                                        −1.6
    *Ubtf*                                                      Upstream binding transcription factor, RNA poly I           1389830_at                                                       AI105117                                                        −1.3
    *Yc2*                                                       Glutathione S-transferase Yc2 subunit                       1371089_at                                                       NM_001009920                                                    −1.2
    *Adamts1*                                                   A disintegrin-like and metalloprotease                      1368223_at                                                       NM_024400                                                       1.5
    *Adcyap1r1*                                                 Adenylate cyclase activating polypeptide 1 receptor 1       1387302_at                                                       NM_133511                                                       1.6
    *Agtr2*                                                     Angiotensin II receptor, type 2                             1369711_at                                                       NM_012494                                                       1.5
    *Atf5*                                                      Activating transcription factor 5                           1372601_at                                                       NM_172336                                                       1.7
    *Ccng1*                                                     Cyclin G1                                                   1367764_at                                                       NM_012923                                                       1.3
    *Clu*                                                       Clusterin                                                   1367784_a\_at                                                    NM_053021                                                       1.5
    *Ctsl*                                                      Cathepsin L                                                 1370244_at                                                       NM_013156                                                       1.2
    *Fabp5*                                                     Fatty acid binding protein 5, epidermal                     1370281_at                                                       NM_145878                                                       1.4
    *Ghrl*                                                      Ghrelin precursor                                           1387254_at                                                       NM_021669                                                       1.7
    *Grm1*                                                      Glutamate receptor, metabotropic 1                          1371180_a\_at                                                    NM_017011                                                       1.7
    *Gstp1*                                                     Glutathione-S-transferase, pi 1                             1388122_at                                                       NM_012577                                                       1.3
    *Lta*                                                       Lymphotoxin A                                               1368722_at                                                       NM_080769                                                       1.3
    *Ms4a2*                                                     Membrane-spanning 4-domains, subfamily A2                   1369399_at                                                       NM_012845                                                       1.6
    *Nupr1*                                                     Nuclear protein 1 "P8"                                      1367847_at                                                       NM_053611                                                       1.8
    *Plau*                                                      Plasminogen activator, urokinase                            1387675_at                                                       NM_013085                                                       1.3
    *Ptprc*                                                     Protein tyrosine phosphatase, receptor type, C              1390798_at                                                       BF288130                                                        1.5
    *Th*                                                        Tyrosine hydroxylase                                        1387075_at                                                       NM_012740                                                       1.4
    *Tpm3*                                                      Tropomyosin isoform 6                                       1376929_at                                                       NM_057208                                                       1.7
    *Ubd*                                                       Ubiquitin D                                                 1368762_at                                                       NM_053299                                                       1.7
    *Unc13a*                                                    Unc-13 homolog A                                            1369330_at                                                       NM_022861                                                       2.3
    *Vipr1*                                                     Vasoactive intestinal peptide receptor 1                    1387561_at                                                       NM_012685                                                       1.8

Gene symbols and accession numbers from Affymetrix Netaffx (<http://www.affymetrix.com/analysis/index.affx>)

###### 

List of significantly altered oxidoreductase gene expression in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk.

  Gene Symbol[^a^](#tfn8-tog-1-2006-033){ref-type="table-fn"}   Gene Name[^a^](#tfn8-tog-1-2006-033){ref-type="table-fn"}   Affymetrix No.[^a^](#tfn8-tog-1-2006-033){ref-type="table-fn"}   Accession No.[^a^](#tfn8-tog-1-2006-033){ref-type="table-fn"}   Fold Change
  ------------------------------------------------------------- ----------------------------------------------------------- ---------------------------------------------------------------- --------------------------------------------------------------- -------------
  Control versus Low                                                                                                                                                                                                                                         
    *Adh1*                                                      Alcoholdehydrogenase1                                       1368021_at                                                       NM_130780                                                       −1.298
    *Cox8h*                                                     Cytochrom c oxidase subunit VIII-H                          1367739_at                                                       NM_012786                                                       −1.888
    *Cyp2e1*                                                    Cytochrome P450,f amily 2, subfamily e1                     1367871_at                                                       NM_031543                                                       −1.347
    *Cyp4a10*                                                   Cytochrome P450, family 4, subfamily a10                    1368934_at                                                       NM_016999                                                       −1.338
    *Fads1*                                                     Fatty acid desaturase 1                                     1367857_at                                                       NM_053445                                                       −1.333
    *P4ha1*                                                     Procollagen-proline,alpha 1 polypeptide                     1370954_at                                                       NM_172062                                                       −1.365
    *Phgdh*                                                     3-phosphoglycerate dehydrogenase                            1367811_at                                                       NM_031620                                                       −1.525
    *Sord*                                                      Sorbitol dehydrogenase                                      1369635_at                                                       NM_017052                                                       −1.437
    *Txnrd1*                                                    Thioredoxin reductase 1                                     1386958_at                                                       NM_031614                                                       −1.319
    *Xdh*                                                       Xanthine dehydrogenase                                      1369973_at                                                       NM_017154                                                       −1.386
    *Gpd2*                                                      Glycerol-3-phosphate dehydrogenase 2                        1369666_at                                                       NM_012736                                                       1.504
  Control versus High                                                                                                                                                                                                                                        
    *Adh1*                                                      Alcohol dehydrogenase 1                                     1368021_at                                                       NM_130780                                                       −1.396
    *Aldh1a1*                                                   Aldehyde dehydrogenase family 1, member A1                  1387022_at                                                       NM_022407                                                       −1.235
    *Cyp2e1*                                                    Cytochrome P450,family 2, subfamily e1                      1367871_at                                                       NM_031543                                                       −1.341
    *Cyp4a10*                                                   Cytochrome P450, family 4, subfamily a10                    1368934_at                                                       NM_016999                                                       −1.341
    *Ehhadh*                                                    3-hydroxyacyl coenzyme A dehydrogenase                      1368283_at                                                       NM_133606                                                       −1.389
    *Fmol1*                                                     Flavin containing monooxygenase 1                           1387053_at                                                       NM_012792                                                       −1.240
    *Hadhsc*                                                    L-3-hydroxyacyl-Coenzyme A dehydrogenase                    1370237_at                                                       NM_057186                                                       −1.280
    *Hpd*                                                       4-hydroxyphenylpyruvic acid dioxygenase                     1368188_at                                                       NM_017233                                                       −1.288
    *P5*                                                        Thioredoxin domain containing 7                             1376239_at                                                       NM_001004442                                                    −1.910
    *Phgdh*                                                     3-phosphoglycerate dehydrogenase                            1367811_at                                                       NM_031620                                                       −1.426
    *Ptgds*                                                     Prostaglandin D2 synthase                                   1367851_at                                                       NM_013015                                                       −1.464
    *Sord*                                                      Sorbitol dehydrogenase                                      1369635_at                                                       NM_017052                                                       −1.320
    *Suox*                                                      Sulfite oxidase                                             1370036_at                                                       NM_031127                                                       −1.387

Gene symbols and accession numbers from Affymetrix Netaffx (<http://www.affymetrix.com/analysis/index>
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CD

:   collecting duct,

DBPs

:   disinfection by-products,

DCT

:   distal convoluted tubules,

DEG

:   differently expressed genes,

K

:   potassium,

KBrO3

:   potassium bromate,

LH

:   loop of Henle,

ppm

:   part per million,

PCT

:   proximal convoluted tubules,

QRT-rtPCR

:   Quantitative Real Time-rtPCR,

THMs

:   trihalomethanes.

![Kidney development gene response in F344 male rats exposed to KBrO~3~ in drinking water. Kidney development gene groups were defined in Stuart et al. (2003) and applied to our data as described in the methods section. For each group of genes, the expression was normalized to control and an average response was calculated for: 52 wk low (20 ppm) KBrO~3~, 52 wk high (400 ppm) KBrO~3~, and 100 wk KBrO~3~-induced adenomas. For each group, the average fold change normalized to control was plotted on the y-axis.](tog-1-2006-033f1A){#f1A-tog-1-2006-033}

![Gene expression pattern in F344 male rats exposed to high KBrO~3~ mimics adenoma expression pattern. Kidney development gene groups were defined in Stuart et al. (2003) and applied to our data as described in the methods section. The differentially expressed genes in the 100 wk KBrO~3~-induced adenomas were categorized into kidney development groups. The top ten genes from each developmental group were then used in the 52 wk low (20 ppm) and high (400 ppm) KBrO~3~ exposed animals. For these 50 genes, the high exposure group showed a similar expression pattern to the adenomas across kidney development groups.](tog-1-2006-033f1B){#f1B-tog-1-2006-033}

![Affymetrix array and QRT-rtPCR fold-change results of select kidney genes of interest from male F344 rats exposed to 400 ppm KBrO~3~ for 52 wk.](tog-1-2006-033f2){#f2-tog-1-2006-033}

![Figure 3A (20 ppm) and 3B (400 ppm) show the location within the kidney nephron of specific genes associated with kidney function from male rats exposed to KBrO~3~ for 52 wk. Genes in green and red font are down-regulated and up-regulated respectively. G: glomerulus, PCT: proximal convoluted tubules, LH: loop of Henle, DCT: distal convoluted tubules, and CD: collecting duct.](tog-1-2006-033f3){#f3-tog-1-2006-033}

###### 

Results of the statistical comparison between 52 wk low, 52 wk high, 100 wk high, and 100 wk adenoma and their corresponding control. Shown are the numbers of genes less than 0.01 that contribute to the p-value calculation as given in the methods. The resultant p-value and the number of false positives are shown, as well as the number of differentially expressed and annotated genes. The gene expression probe array used was the Affymetrix Rat Expression Array 230A gene chip containing 15,866 probe sets.

  **Treatment**                                                    **Genes \< 0.01**   **P-value**   **False Positives**   **Differentially Expressed**   **Annotated**
  ---------------------------------------------------------------- ------------------- ------------- --------------------- ------------------------------ ---------------
  52 wk low (3)[^\*^](#tfn1-tog-1-2006-033){ref-type="table-fn"}   470                 0.00128       21                    144                            99
  52 wk high (3)                                                   603                 0.00189       30                    224                            139
  100 wk high (2)                                                  244                 0.000766      13                    43                             27
  100 wk adenomas (2)                                              1431                0.0045        72                    994                            671

The sample size for the comparison is shown with the treatment group.

###### 

Gene ontology (GO) analysis of differentially expressed genes (DEG) in kidneys from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. Results are the number of differentially expressed genes within a functional group that were either up or down regulated, with group total. Functional analyses for all groups were compiled by individual gene review.

  **Functional Group[^\*^](#tfn2-tog-1-2006-033){ref-type="table-fn"}**   **Control versus Low**   **Control versus High**                  
  ----------------------------------------------------------------------- ------------------------ ------------------------- ---- ---- ---- ----
  Oxidative Stress                                                        4                        0                         4    5    5    10
  Lipid Metabolism                                                        6                        4                         10   9    1    10
  Kidney Function                                                         10                       3                         13   20   3    23
  Oxidoreductase                                                          10                       1                         11   13   0    13
  Cell Function                                                           30                       10                        40   20   22   42

A total of 99 and 139 genes were used for gene ontology analyses from low and high exposure concentrations respectively.

###### 

List of differentially expressed oxidative stress genes in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. All comparisons were made between the specific treatment group and their corresponding control.

  **Gene Symbol[^a^](#tfn3-tog-1-2006-033){ref-type="table-fn"}**   **Gene Name[^a^](#tfn3-tog-1-2006-033){ref-type="table-fn"}**   **Affymetrix No.[^a^](#tfn3-tog-1-2006-033){ref-type="table-fn"}**   **Accession No.[^a^](#tfn3-tog-1-2006-033){ref-type="table-fn"}**   **Fold Change**
  ----------------------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------- -----------------
  Low dose                                                                                                                                                                                                                                                                   
    *Dscr*1                                                         Down syndrome critical region homolog 1                         1388686_at                                                           NM_153724                                                           −1.4
    *Hspb*1                                                         Heat shock protein                                              1367577_at                                                           NM_031970                                                           −1.5
    *Txnrd*1                                                        Thioredoxin reductase 1                                         1386958_at                                                           NM_031614                                                           −1.4
    *Xdh*                                                           Xanthine dehydrogenase                                          1369973_at                                                           NM_017154                                                           −1.4
  High dose                                                                                                                                                                                                                                                                  
    *Dscr*1                                                         Down syndrome critical region homolog 1                         1388686_at                                                           NM_153724                                                           −1.3
    *Gnmt*                                                          Glycine N-methyltransferase                                     1387672_at                                                           NM_017084                                                           −1.3
    *Gsta*2                                                         Glutathione S-transferase A2                                    1368180_s\_at                                                        NM_017013                                                           −1.2
    *Hspbap*1                                                       Heat shock associated protein                                   1368195_at                                                           NM_134419                                                           −1.8
    *Pex*11*a*                                                      Peroxisomal biogenesis factor 11a                               1379361_at                                                           NM_053487                                                           −1.3
    *Ccng*1                                                         Cyclin G1                                                       1367764_at                                                           NM_012923                                                           1.3
    *Cp*                                                            Ceruloplasmin (ferroxidase)                                     1368418_a\_at                                                        NM_012532                                                           1.3
    *Gclm*                                                          Glutamate-cysteine ligase, modifier subunit                     1370030_at                                                           NM_017305                                                           1.3
    *Gstm*1                                                         Glutathione S-transferase M 1                                   1386985_at                                                           NM_017014                                                           1.4
    *Gstp*1                                                         Glutathione S-transferase Pi 1                                  1388122_at                                                           NM_012577                                                           1.3

Gene symbols and accession numbers from Affymetrix Netaffx (<http://www.affymetrix.com/analysis/index.affx>).

###### 

List of differentially expressed kidney function/ion transport genes in kidney from male rats exposed to 20 ppm (low) and 400 ppm (high) potassium bromate in drinking water for 52 wk. All comparisons were made between the specific treatment group and their corresponding control.

  **Gene Symbol[^a^](#tfn4-tog-1-2006-033){ref-type="table-fn"}**   **Gene Name[^a^](#tfn4-tog-1-2006-033){ref-type="table-fn"}**   **Affymetrix No.[^a^](#tfn4-tog-1-2006-033){ref-type="table-fn"}**   **Accession No.[^a^](#tfn4-tog-1-2006-033){ref-type="table-fn"}**   **Fold Change**
  ----------------------------------------------------------------- --------------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------- -----------------
  Low dose                                                                                                                                                                                                                                                                   
    *Aqp*1                                                          Aquaporin 1                                                     1387651_at                                                           NM_012778                                                           −1.3
    *Atp*1*a*1                                                      ATPase, Na+/K+ transporting, alpha 1                            1371108_a\_at                                                        NM_012504                                                           −1.2
    *Dscr*1                                                         Down syndrome critical region homolog 1                         1388686_at                                                           NM_153724                                                           −1.4
    *G*6*pc*                                                        Glucose-6-phosphatase,                                          1386944_a\_at                                                        NM_013098                                                           −1.7
    *Ramp*3                                                         Receptor (calcitonin) activity modifying protein 3              1387389_at                                                           NM_020100                                                           −1.9
    *Sgk*                                                           Serum/glucocorticoid regulated kinase                           1367802_at                                                           NM_019232                                                           −1.6
    *Slc*15*a*1                                                     Solute carrier family 15, member 1                              1369381_a\_at                                                        NM_057121                                                           −1.5
    *Slc*16*a*1                                                     Solute carrier family 16, member 1                              1386981_at                                                           NM_012716                                                           −2.8
    *Slc*22*a*1                                                     Solute carrier family 22, member 1                              1368191_a\_at                                                        NM_012697                                                           −1.5
    *Xdh*                                                           Xanthine dehydrogenase                                          1369973_at                                                           NM_017154                                                           −1.4
    *Calca*                                                         Calcitonin/calcitonin-related polypeptide, alpha                1370775_a\_at                                                        NM_017338                                                           1.4
    *Cldn*16                                                        Claudin 16                                                      1369184_at                                                           NM_131905                                                           1.4
    *Slc*21*a*4                                                     Kidney specific organic anion, scf 21, member 4                 1368498_a\_at                                                        NM_030837                                                           1.4
  High dose                                                                                                                                                                                                                                                                  
    *Aqp*2                                                          Aquaporin 2                                                     1368568_at                                                           NM_012909                                                           −1.4
    *Aqp*3                                                          Aquaporin 3                                                     1387100_at                                                           NM_031703                                                           −1.4
    *Calb*1                                                         Calbindin 1                                                     1370201_at                                                           NM_031984                                                           −1.3
    *Clcnk*11                                                       Chloride channel K1-like                                        1388175_at                                                           NM_173103                                                           −1.4
    *Dscr*1                                                         Down syndrome critical region homolog 1                         1388686_at                                                           NM_153724                                                           −1.4
    *Edn*1                                                          Endothelin 1                                                    1369519_at                                                           NM_012548                                                           −1.4
    *Kcnj*16                                                        Potassium inwardly-rectifying channel, J16                      1373991_at                                                           AI411366                                                            −1.2
    *Kcnq*1                                                         Potassium voltage-gated channel, KQT-like 1                     1368371_at                                                           NM_032073                                                           −1.4
    *Ngfg*                                                          Nerve growth factor, gamma subunit                              1367961_at                                                           NM_031523                                                           −1.9
    *Prkwnk*4                                                       Protein kinase, lysine deficient 4                              1389662_at                                                           NM_175579                                                           −1.6
    *Scnn*1*a*                                                      Sodium channel nonvoltage-gated 1A                              1387104_at                                                           NM_031548                                                           −1.3
    *Scnn*1*g*                                                      Sodium channel nonvoltage-gated 1G                              1370481_at                                                           NM_017046                                                           −1.5
    *Slc*5*a*2                                                      Solute carrier family 5, member 2                               1368414_at                                                           NM_022590                                                           −1.4
    *Slc*9*a*3                                                      Solute carrier family 9 (Na/H exchanger), isoform 3             1387542_at                                                           NM_012654                                                           −1.3
    *Slc*12*a*3                                                     Solute carrier family 12 (Na/Cl transporters), 3                1387230_at                                                           NM_019345                                                           −1.4
    *Slc*13*a*3                                                     Solute carrier family 13 Na+ transport, member 3                1368047_at                                                           NM_022866                                                           −1.3
    *Slc*22*a*5                                                     Solute carrier family 22, member 5                              1367950_at                                                           NM_019269                                                           −1.3
    *Slc*22*a*8                                                     Solute carrier family 22, member 8                              1368461_at                                                           NM_031332                                                           −1.3
    *Slc*26*a*4                                                     Pendrin, solute carrier family 26, member 4                     1368193_at                                                           NM_019214                                                           −4.6
    *Slc*37*a*4                                                     Solute carrier family 37, member 4                              1386960_at                                                           NM_031589                                                           −1.3
    *Agtr*2                                                         Angiotensin II receptor, type 2                                 1369711_at                                                           NM_012494                                                           1.5
    *Cldn*16                                                        Claudin 16                                                      1369184_at                                                           NM_131905                                                           1.6
    *Cp*                                                            Ceruloplasmin (ferroxidase)                                     1368418_a\_at                                                        NM_012532                                                           1.3
    *Slc*12*a*1                                                     Solute carrier family 12 (Na/K/Cl), member 1                    1368548_at                                                           NM_019134                                                           1.5

Gene symbols and accession numbers from Affymetrix Netaffx (<http://www.affymetrix.com/analysis/index.affx>).

###### 

List of similar genes between 52 wk high dose potassium bromate (400 ppm), 100 wk high dose, and adenomas (n = 2) that occurred at 100 wk. This list of genes may be usable as tumor marker genes. All comparisons were made between the specific treatment group and their corresponding control.

  **Gene Symbol[^a^](#tfn5-tog-1-2006-033){ref-type="table-fn"}**   **Affymetrix No.[^a^](#tfn5-tog-1-2006-033){ref-type="table-fn"}**   **Accession No.[^a^](#tfn5-tog-1-2006-033){ref-type="table-fn"}**   **52 wk High Dose Fold Change**   **100 wk High Dose Fold Change**   **Adenoma Fold Change**
  ----------------------------------------------------------------- -------------------------------------------------------------------- ------------------------------------------------------------------- --------------------------------- ---------------------------------- -------------------------
  *Calb*1                                                           1370201_at                                                           NM_031984                                                           −1.3                              −11.4                              −153.4
  *Gp*2                                                             1386933_at                                                           NM_134418                                                           −2.2                              −11.9                              −18.6
  *Klk*7                                                            1387820_at                                                           NM_012593                                                           −1.4                              −12.1                              −57.3
  *LOC*362802                                                       1376239_at                                                           NM_001014199                                                        −1.9                              −3.6                               −2.6
  *Ngfg*                                                            1367961_at                                                           NM_031523                                                           −1.9                              −20.5                              −77.3
  *Prps*2                                                           1375932_at                                                           NM_012634                                                           −1.4                              −2.9                               −2.6
  *Slc*12*a*3                                                       1387230_at                                                           NM_019345                                                           −1.4                              −4.8                               −6.6
  *Slc*26*a*4                                                       1368193_at                                                           NM_019214                                                           −4.6                              −6.0                               −6.3

Gene symbols and accession numbers from Affymetrix Netaffx (<http://www.affymetrix.com/analysis/index.affx>).
